Study on the Impact of Vitamin C and E on Diabetes Control in Adults.

Impact of Vitamin C and E Supplementation on Glycemic Control in Adults with Type 2 Diabetes Mellitus Receiving Standard Treatment: A Randomized Controlled Trial. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096179

Enrollment

Registered

2025-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

Intervention1: Vitamin C and Vitamin E: Standard therapy + daily supplementation of vitamin C (500 mg) and vitamin E (400 mg) for 12 weeks Intervention2: Supplement: Oral intake of Vitamin C and E tab

Eligibility

Inclusion criteria

Inclusion criteria: T2DM patients receiving standard antidiabetic medication. Willing and able to provide informed consent.

Exclusion criteria

Exclusion criteria: Type 1 Diabetes Mellitus patients. Diabetic complications, such as: retinopathy, nephropathy, neuropathy, ketoacidosis, or hyperosmolar state Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
To evaluate the change in glycemic control and insulin resistance from baseline to 12 weeksTimepoint: Baseline (week 0), Weeks 4,8 and 12	—

Secondary

Measure	Time frame
To evaluate the adverse effects and tolerability of vitamin C and E supplementation in type 2 diabetic patients. To assess the effect of vitamin C and E supplementation on blood pressure in type 2 diabetic patients. Timepoint: Baseline (week 0), Weeks 4,8 and 12	—

Countries

India

Contacts

Public ContactInfant Nikitha R

SRM College of Pharmacy, SRMIST

Nandimak1@srmist.edu.in8500768402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026